2559
PROGNOSIS
FACTORS OF PERSISTENT HEPATIC DAMAGE IN CHILDREN YOUNGER THAN 5 YEARS WITH
ACETMINOPHEN POISONING Escalante GP1, Montoya CMA1,
Talavera PJO2 1 Hospital de
Pediatria. Centro Medico Nacional Siglo XXI. Instituto Mexicano del Seguro
Social. Mexico DF. Mexico city 2 Unidad de Investigacion de Epidemiologia, Hospital de
Especialidades, Centro Medico Nacional Siglo XXI, Instituto Mexicano del
Seguro Socia. Mexico, D.F. Mexico city Objective: To know the prognosis factors in the
development of persistent hepatic damage (PHD) for more than 72 hours in
children younger than 5 years with acetaminophen (ACM) poisoning and
antidotal treatment with N-acetylcysteine (NAC). Methods: prospective cohort study. We studied 108
patients, were made concentrations trials for acetaminophen, prothrombin
time and hepatic function tests at 24,48 and 72 hours with clinical
evaluation, when ACM levels were above of the therapeutic levels(20 μg/dl), treatment with NAC was given, also were
made serological tests for hepatitis A, B, C and a questionary for the
variables in study. Results:
Were excluded 9 patients. Of the 99
remainder, 20 had PHD caused by acetaminophen. The mean age in months was
20+/-6, In the bivariate analysis than had a relative risk>2 and the
confidence interval 95% were the use with drugs inductive of the microsomal
hepatic system (IMHS), clinical phase (CP) of toxicity II, III and the
levels of ACM. In the multiple logistic regression the significance of age
was from 3 to 12 months and the use of IMHS. In the analysis of connected
consolidation of age with the use of IMHS, alpha 47 Children, 8.5% of probability of PHD in children
>12 months of age; beta: 40 children from 3 to 12 months of age without
IMHS, 25% of PHD; and gamma 12 patients with IMHS, probability 50% for PHD.
In the CP, stratum A age >12 months without IMHS, CPI, PHD 3.3%, B in CP
I or II with age < or >12 months, PHD 20% and C any age with IMHS or
in CP III 57% of PHD. Conclusion: A prognostic index was obtained, according to
the 3 significant variables that you can apply without necessity of ACM
levels. This
confirms that in children < 12 months of age, exposed to multiple doses
of ACM have a bad prognostis for PHD.